ArticleJournal of medicinal chemistry2026

Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity.

Bin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.